About Rovia
Consistent, Predictable and Effective Results in Clinical Trial Management
That’s where Rovia comes in. Study to study, phase to phase, patient to patient…Rovia consistently delivers results to patients and life science partners.
For the past 18 years, our teams have a proven track record of delivering precise and timely study results through meticulous data collection and analysis. Our efficient processes enable seamless communication within our research team and with external partners. Our combination of free-standing sites and sites embedded in physician offices, allows us to effectively recruit for high and low complex studies.
Leadership
Members of our management group share a passion for clinical research and a commitment to provide both a positive experience for patients and unfailingly accurate, productive results for sponsors and investigators. Leading teams of world-class clinicians, technical experts, academicians and researchers, each of our senior executives is dedicated to improving the lives and health of others in keeping with Rovia’s mission.
Patricio Casillas
Chief Executive Officer
Patricio brings over 20 years of leadership experience in Healthcare across various sectors including pharma, med device, value-based primary care, pharmacy and DME. He earned a B.S. in Biology from Duke University and an M.B.A from Stanford University. He’s an alum of Eli Lilly, Johnson & Johnson. Patricio is passionate about expanding the access of breakthrough therapies to patients in order to increase quality of life, reduce disease burden and reduce the overall cost of healthcare. He enjoys tennis, golf, reading and spending time with his wife and two kids.
Derick Jaindl
Chief Financial Officer
Mr. Jaindl offers over 20 years of experience in organizational development, focusing on finance, strategic planning, and cross-functional team building. He earned a Master of Accounting from the University of Miami, an MBA from Drexel University, and a Bachelor’s in Finance from Babson College. A graduate of GE’s Financial Management and Six Sigma programs and a licensed CPA, Mr. Jaindl has played vital roles in expanding debt facilities, acquisitions, and business exits. His previous leadership positions include CFO at MobileHelp and roles at Mednax, Tyco International, and Comcast.
Jeff Repper
Chief Operating Officer
Jeff joins us with an impressive track record of 20+ years of leadership and success in clinical research and operational management. Jeff holds a Bachelor of Arts in Technical and Scientific Communication from Miami University and has completed leadership training through Sandler & Blue Harbor.
Rebecca Goldfaden
Chief Scientific Officer & Head of Business Development
Rebecca has over 15 years of clinical research experience and has successfully built and scaled research sites across multiple therapeutic areas. She also leads Rovia’s investigator-led research program. Rebecca previously served as a Clinical Assistant Professor for several Colleges of Pharmacy across the U.S. She earned her Doctorate of Pharmacy from the University of Florida and completed a
PGY-1 Pharmacy Residency at James A. Haley Veterans’ Hospital, focusing on cardiology and endocrinology. She later completed a two-year Post-Doctoral Fellowship in Clinical Research and the Pharmaceutical Industry, where her passion for clinical research grew. Rebecca is dedicated to educating her community about clinical research and expanding access to new opportunities.
Our Site Brands
Rovia’s diverse portfolio features a collection of companies each specializing in different aspects of the clinical research industry. These brands aim to advance healthcare through innovative research methods, diverse patient engagement strategies, and technology integration. By leveraging their expertise, Rovia’s brands collaborate to enhance the clinical trial experience, streamline drug development, and address critical medical needs, ultimately contributing to the advancement of medical science and better patient outcomes.
